GPC1 and pancreatic neoplasm: CA19-9 serum levels cannot distinguish patients with intraductal papillary mucinous tumors (PCPL) from healthy controls, while GPC1-positive serum exosomal had 100% sensitivity and specificity in all stages of pancreatic cancer (e.